Literature DB >> 11270545

Retrosigmoid approach to acoustic neuroma (vestibular schwannoma).

R G Ojemann1.   

Abstract

The retrosigmoid approach for the microsurgical removal of an acoustic neuroma (vestibular schwannoma) is described, and perioperative medical management of the patient is discussed. The techniques for monitoring facial and cochlear nerve function are presented. The supine-oblique position, skin incision, bone removal, dural opening, and initial exposure are outlined. Important points in the technique for removing acoustic neuromas and preserving hearing, when possible, are described and illustrated.

Entities:  

Mesh:

Year:  2001        PMID: 11270545     DOI: 10.1097/00006123-200103000-00018

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Surface anatomy of the posterolateral cranium regarding the localization of the initial burr-hole for a retrosigmoid approach.

Authors:  Mustafa Bozbuga; Burak O Boran; Kayihan Sahinoglu
Journal:  Neurosurg Rev       Date:  2005-10-15       Impact factor: 3.042

2.  Virtual cisternoscopy: 3D MRI models of the cerebellopontine angle for lesions related to the cranial nerves.

Authors:  James D Rabinov; Frederick G Barker; Michael J McKenna; Hugh D Curtin
Journal:  Skull Base       Date:  2004-05

3.  Localization of transverse-sigmoid sinus junction using preoperative 3D computed tomography: application in retrosigmoid craniotomy.

Authors:  Lei Xia; Mingshan Zhang; Yanming Qu; Ming Ren; Haoran Wang; Hongwei Zhang; Chunjiang Yu; Mingwang Zhu; Jianhua Li
Journal:  Neurosurg Rev       Date:  2012-05-22       Impact factor: 3.042

4.  Dorsal displacement of the facial nerve in acoustic neuroma surgery: clinical features and surgical outcomes of 21 consecutive dorsal pattern cases.

Authors:  Takahide Nejo; Michihiro Kohno; Osamu Nagata; Shigeo Sora; Hiroaki Sato
Journal:  Neurosurg Rev       Date:  2015-12-01       Impact factor: 3.042

Review 5.  Post-operative complications after removal of sporadic vestibular schwannoma via retrosigmoid-suboccipital approach: current diagnosis and management.

Authors:  Stylianos Charalampakis; Dimitrios Koutsimpelas; Haralampos Gouveris; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-11       Impact factor: 2.503

Review 6.  Functional outcomes in retrosigmoid approach microsurgery and gamma knife stereotactic radiosurgery in vestibular schwannoma.

Authors:  Cheol Eon Park; Bong Jin Park; Young Jin Lim; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-11       Impact factor: 2.503

7.  Koos grade IV vestibular schwannomas: considerations on a consecutive series of 60 cases-searching for the balance between preservation of function and maximal tumor removal.

Authors:  Luciano Mastronardi; Alberto Campione; Fabio Boccacci; Carlo Giacobbo Scavo; Ettore Carpineta; Guglielmo Cacciotti; Raffaelino Roperto; Albert Sufianov; Ali Zomorodi
Journal:  Neurosurg Rev       Date:  2021-02-18       Impact factor: 3.042

8.  A Prospective Evaluation of Swallowing and Speech in Patients with Neurofibromatosis Type 2.

Authors:  Sibi Rajendran; Joseph Antonios; Beth Solomon; H Jeffrey Kim; Tianxia Wu; James Smirniotopoulos; Gretchen Scott; Sarah Benzo; Christina Hayes; John D Heiss; Prashant Chittiboina
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-18

9.  Microsurgical treatment of symptomatic vestibular schwannomas in patients under 40: different results before and after age of 30.

Authors:  Luciano Mastronardi; Alberto Campione; Guglielmo Cacciotti; Ettore Carpineta; Carlo Giacobbo Scavo; Raffaele Roperto; Giovanni Stati; Albert A Sufianov; Karl Schaller
Journal:  Neurosurg Rev       Date:  2021-08-17       Impact factor: 3.042

10.  Removal of large acoustic neurinomas (vestibular schwannomas) by the retrosigmoid approach with no mortality and minimal morbidity.

Authors:  I Yamakami; Y Uchino; E Kobayashi; A Yamaura; N Oka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.